tiprankstipranks
Trending News
More News >
Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ:TELO
US Market
Advertisement

Telomir Pharmaceuticals, Inc. (TELO) Revenue

Compare
203 Followers

Telomir Pharmaceuticals, Inc. Revenue

Telomir Pharmaceuticals, Inc. had a revenue of 0.00 in the quarter ending Jun 30, 2025, with ―. This bring the company's revenue in the last twelve months to 18.79M, Decreased 0.00%. In the fiscal year ending Dec 31, 2024, Telomir Pharmaceuticals, Inc. had annual revenue of 0.00 with ― growth.
Revenue (ttm)
18.79M
Revenue Growth
P/S Ratio
Revenue/Employee
$0
Employees
1
Market Cap
$42.29M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis